See listings for leiomyosarcoma trials:
View leiomyosarcoma trials listed at ClinicalTrials.gov.
View leiomyosarcoma trials listed at Inclinicaltrials.com.
Resources for understanding terminology in clinical trial listings:
The National Cancer Institute’s Cancer Drug Dictionary
The NCI’s Dictionary of Cancer Terms
The ClinicalTrials.gov Glossary of Common Site Terms defines terms used on their website.
View: KEYNOTE Oncology Clinical Immunotherapy Trials for Solid Tumors:
Pembrolizumab is an investigational immunotherapy that may help the body’s immune system attack cancer cells. When a cancer cell binds to an immune cell, the immune cell can’t do its job. These trials want to see if pembrolizumab can block cancer cells from binding with immune cells to help allow the immune cells to work properly.
Participating in a clinical trial is an important decision. Anyone participating in a trial should know as much as possible about what is being studied, what risks are involved and what potential benefits may be gained before deciding to enroll. If you are interested in participating in a clinical trial, please talk to your doctor first.